BOGOTÁ, Colombia & TORONTO--(BUSINESS WIRE)-- Sun Valley Investments AG (“Sun Valley”) announces the closing of the second tranche of its previously announced transaction pursuant to which Sun Valley acquired 7,463,462 common shares (“Acquired Securities”) of Mineros S.A. (“Mineros” or the "Company", TSX: MSA, CB: MINEROS) from Banderato Colombia S.A.S. (the "Vendor") at a price of C$0.836 per share for aggregate consideration of C$6,239,454.23 (the... (continue reading...)
NEW YORK--(BUSINESS WIRE)-- The University of Texas Wind Ensemble, hailed as one of America’s truly elite wind bands, marks its 50th anniversary with a performance at Carnegie Hall in the Isaac Stern Auditorium / Ronald O. Perelman Stage on Sunday, June 2, 2024 at 2pm. Led by the esteemed conductor Jerry Junkin, the ensemble has earned accolades for its exhilarating color, profound music-making, and remarkable virtuosity, solidifying its reputation as a musical... (continue reading...)
HOUSTON--(BUSINESS WIRE)-- Halliburton Company (NYSE: HAL) announced today that at its annual meeting of shareholders held in Houston, Texas, on May 15, 2024, the shareholders elected all 12 nominees to the Company’s board of directors. Shareholders elected board members Abdulaziz F. Al Khayyal, William E. Albrecht, M. Katherine Banks, Alan M. Bennett, Earl M. Cummings, Murry S. Gerber, Robert A. Malone, Jeffrey A. Miller, Bhavesh V. Patel, Maurice S. Smith, Janet... (continue reading...)
OLDWICK, N.J.--(BUSINESS WIRE)-- AM Best has assigned a Long-Term Issue Credit Rating (Long-Term IR) of “a-” (Excellent) to the $650 million, 5.75% senior unsecured notes, due Sept. 15, 2034, recently issued by Reinsurance Group of America, Incorporated (RGA) (Chesterfield, MO) [NYSE: RGA]. The outlook assigned to this Credit Rating (rating) is stable. All other ratings of RGA and its insurance subsidiaries remain unchanged.
The proceeds from the sale of the... (continue reading...)
Late-breaking data from pivotal Phase III studies OASIS 1 and 2 to be presented at 2024 ACOG Annual Meeting:
- Pivotal OASIS 1 and 2 Phase III studies of investigational compound elinzanetant achieved a statistically significant reduction in frequency and severity of vasomotor symptoms (VMS; also known as hot flashes) over 12 weeks compared to placebo
- Consistent benefits were also seen across both studies in all three key secondary endpoints, with significant... (continue reading...)
More Business Wire
View Older Stories-
Falcon’s Beyond Announces First Quarter 2024 Results
-
Allstate CEO to present at William Blair Growth Stock Conference
-
Rubicon Technologies to Hold First Quarter 2024 Earnings Call on May 20
-
Cirrus Logic Announces CFO Transition
-
Browning West Announces the Dismissal of All Frivolous Lawsuits Brought by Gildan Activewear’s Board Ahead of Upcoming Annual Meeting
-
Tassat® Partners with Glasstower Digital on Cross-Border Digital B2B Payments
-
AM Best Comments on Credit Ratings of Members of Corebridge Financial Following Announced Agreement
-
World Still in the Dark on COVID-19’s Origins, says AHF
-
Cleveland Bakers and Teamsters Health and Welfare Fund Partners with Curio Digital Therapeutics to Revolutionize Maternal Mental Health Support for Members
-
OptionMetrics Exhibiting at BattleFin Discovery Day New York May 21 & 22
-
JPMorgan Chase to Present at the Morgan Stanley U.S. Financials and Payments Conference
-
NGL Energy Partners Announces Earnings Call
-
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Piedmont Announces Upcoming Conference Participation
-
Materion to Participate in KeyBanc’s Industrials and Basic Materials Conference
-
Cable One Declares Quarterly Dividend
-
Intel Corporation to Participate in Upcoming Investor Conferences
-
dynaCERT Launches $2,500,000 Non-Brokered Private Placement of Equity
-
NW Natural and Modern Hydrogen Unveil Clean Hydrogen Production, Carbon Capture Project in Portland
-
Carter’s, Inc. Announces Quarterly Dividend
-
DXC Technology Reports Fourth Quarter and Full Fiscal Year 2024 Results
-
AltaLink, L.P. to issue $325 Million in Senior Secured Notes
-
New Advisor for Simplify Market Neutral Equity Long/Short ETF
-
Copart Reports Third Quarter Fiscal 2024 Financial Results
-
Genesco to Report First Quarter Fiscal 2025 Results and Hold Conference Call on May 31, 2024
-
Two Harbors Investment Corp. to Present at the 2024 KBW Virtual Real Estate Finance & Technology Conference
-
Elastic to Announce Fourth Quarter and Fiscal 2024 Earnings Results on Thursday, May 30, 2024
-
DoubleVerify Announces $150 Million Share Repurchase Program
-
AvalonBay Communities, Inc. Declares Second Quarter 2024 Dividends
-
UWM Announces 0% Down Purchase Program
-
LCI Industries Declares Quarterly Cash Dividend
-
Braze to Report First Quarter Fiscal 2025 Results
-
AXIS Capital Declares Quarterly Dividends and Announces New Share Repurchase Authorization
-
The Baldwin Group to Change Ticker Symbol to BWIN on May 20, 2024
-
Cadre Holdings Announces Participation at Upcoming Investor Conferences
-
Qurate Retail, Inc. Declares Quarterly Cash Dividend on 8.0% Series A Cumulative Redeemable Preferred Stock
-
Logistic Properties of the Americas Announces $120 million Refinancing of Two Logistics Parks in Costa Rica and Peru
-
Zehl & Associates is Finalist for National Law Journal Elite Trial Lawyers Award
-
Comstock Announces Kickoff to Summerbration 2024 at Reston Station
-
Comstock Announces Kickoff to Summerbration 2024 at Loudoun Station
-
Exicure, Inc. Reports Third Quarter 2023 Financial Results
-
KBRA Assigns Preliminary Ratings to Verdant Receivables 2024-1 LLC
-
Despegar.com Announces 1Q24 Financial Results
-
Take-Two Interactive Software, Inc. Reports Results for Fourth Quarter and Fiscal Year 2024
-
Landmark Study Shows CareDx’s HeartCare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsies
-
EVERTEC Announces Successful Repricing of Existing Term Loan B
-
National Storage Affiliates Trust Announces Quarterly Dividends
-
BILL to Participate in Upcoming Investor Conferences
-
Box Announces Appointment of Steve Murphy, CEO of Epicor Software, to its Board of Directors
-
Contineum Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights